Laurie Deleve is a Gastroenterology physician affiliated with University of Southern California. OpenAlex indexes 98 publications with 8,071 citations (h-index 40). By OpenAlex citation count, this profile ranks in the top 10% of Gastroenterology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1520 San Pablo St
Suite 1000
Los Angeles, CA 900335310
Telephone
323-442-5100Provider last certified this registry record 29 Aug 2020.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Inc.Program year20254 payments
- Daiichi Sankyo Inc.Program year20233 payments
- Dr.Reddy's Laboratories,Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
71.7%Guanylate Cyclase-C Agonist39.1%Linzess100%Part D<11 patientsProton pump inhibitor32.6%Omeprazole100%Part D<11 patientsBlood & clotting
28.3%Solutions for parenteral nutrition28.3%Peg 3350-Electrolyte100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 1994–2023 per NIH RePORTER. The latest:
- Liver Sinusoidal Endothelial Cell Progenitor Cells (sprocs) and Chronic Liver Disease
University of Southern California
FY2023$371,250R01DK100580 - Liver Sinusoidal Endothelial Cell Progenitor Cells (sprocs) and Chronic Liver Disease
University of Southern California
FY2022$371,250R01DK100580 - Role of Dietary Nutrients in Induction of Pseudocapillarization and the Functional Consequences for Hyperlipidemia
University of Southern California
FY2022$338,250R56AG071480
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Andrew Moshfeghi, MD
University of Southern California
Kenneth Nies, MD
University of Southern California
Shuntaro Shinada, MD
University of Southern California
Charles Rice, MD
The Rockefeller University
Naga Chalasani, MD
Indiana University School of Medicine
Bruce Sands, MD
Icahn School of Medicine at Mount Sinai
Kris Kowdley, MD
Washington State University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”